From next-generation sequencing to nanopore sequencing technology: Paving the way to personalized genomic medicine

Expert Review of Medical Devices

Volumn 10, Issue 1, 2013, Pages 1-6

  Ku, Chee Seng ^a   Roukos, Dimitrios H ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

biomarkers; cancer; clinical medicine; genome; high throughput sequencing technologies; integrative genomic analysis; mutations; transcriptome

Indexed keywords

GENE SEQUENCE; GENOMICS; HUMAN; MUTATION; NANOPORE; PERSONALIZED MEDICINE; REVIEW; TUMOR GENE;

DNA, NEOPLASM; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; GENETIC TESTING; GENOMICS; HUMANS; INDIVIDUALIZED MEDICINE; NANOSTRUCTURES; NANOTECHNOLOGY; NEOPLASMS; POROSITY; SEQUENCE ANALYSIS, DNA;

EID: 84871970956     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.12.63     Document Type: Review

References (25)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 144(5), 646-674 (2011).
2. Chin L, Andersen JN, Futreal PA. Cancer genomics: From discovery science to personalized medicine. Nature Med. 17, 297-303 (2011).
3. Stratton MR. Exploring the genomes of cancer cells: Progress and promise. Science 331(6024), 1553-1558 (2011).
4. Roukos DH. Next-generation, genome sequencing-based biomarkers: Concerns and challenges for medical practice. Biomark. Med. 4(4), 583-586 (2010).
5. Tran B, Dancey JE, Kamel-Reid S et al. Cancer genomics: Technology, discovery, and translation. J. Clin. Oncol. 30(6), 647-660 (2012).
6. Roukos DH. Next-generation sequencing and epigenome technologies: Potential medical applications. Expert Rev. Med. Devices 7(6), 723-726 (2010).
7. Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8), 1039-1043 (2010).
8. Roukos DH. Trastuzumab and beyond: Sequencing cancer genomes and predicting molecular networks. Pharmacogenomics J. 11(2), 81-92 (2011).
9. Marshall E. Human genome 10th anniversary. Waiting for the revolution. Science 331(6017), 526-529 (2011).
10. Shah SP, Roth A, Goya R et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486(7403), 395-399 (2012).
11. Banerji S, Cibulskis K, Rangel-Escareno C et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486(7403), 405-409 (2012).
12. Ellis MJ, Ding L, Shen D et al. Wholegenome analysis informs breast cancer response to aromatase inhibition. Nature 486(7403), 353-360 (2012).
13. Curtis C, Shah SP, Chin SF et al.; METABRIC Group. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486(7403), 346-352 (2012).
14. Ross-Innes CS, Stark R, Teschendorff AE et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481(7381), 389-393 (2012).
15. Jones DT, Jäger N, Kool M et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488(7409), 100-105 (2012).
16. Northcott PA, Shih DJ, Peacock J et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488(7409), 49-56 (2012).
17. Seshagiri S, Stawiski EW, Durinck S et al. Recurrent R-spondin fusions in colon cancer. Nature 488(7413), 660-664 (2012).
18. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
19. Ideker T, Krogan NJ. Differential network biology. Mol. Syst. Biol. 8, 565 (2012).
20. Camacho DF, Pienta KJ. Disrupting the networks of cancer. Clin. Cancer Res. 18(10), 2801-2808 (2012).
21. Metzker ML. Sequencing technologies Y the next generation. Nat. Rev. Genet. 11, 31-46 (2010).
22. Venkatesan BM, Bashir R. Nanopore sensors for nucleic acid analysis. Nat. Nanotechnol. 6, 615-624 (2011).
23. Pennisi E. Genome sequencing. Search for pore-fection. Science 336(6081), 534-537 (2012).
24. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: Current approaches and outstanding challenges. PLoS Comput. Biol. 8(2), e1002375 (2012).
25. Califano A, Butte AJ, Friend S, Ideker T, Schadt E. Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nat. Genet. 44(8), 841-847 (2012).